Fig. 3
From: Microbiological profile of patients treated for postoperative peritonitis: temporal trends 1999–2019
Annual susceptibility of Enterobacterales to piperacillin/tazobactam (panel A) and cefotaxime (panel B). Results expressed as proportions for the drug. Footnote (panel A. Linear regression in dotted line R2 = 0.298; Cochran–Armitage test p = 0.0005) (panel B. linear regression R2 = 0.480; Cochran–Armitage test p < 0.0001)